Specialty: Mental Health, Primary sub-specialty: Anxiety - emotional
Conditions
Interventions
Current Interventions (as of 10/01/2018):
The study is formed of two phases. 30 participants are recruited to take part in the first phase (control phase) and 30 are recruited to take part in the seco
by adding the pros and cons and weighting the importance of each one. Additionally, user
Sponsors
University College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria (as of 10/08/2018): 1. Recent referral to CAMHS at the point of recruitment 2. Aged 11-19 years 3. Presenting to CAMHS with emotional difficulties, such as anxiety or depression (Strengths and Difficulties Questionnaire score of = 7) 4. Able to understand English sufficiently to provide informed consent 5. Own a smartphone Previous inclusion criteria: 1. Recent referral to CAMHS at the point of recruitment 2. Aged 11-19 years 3. Presenting to CAMHS with emotional difficulties, such as anxiety or depression (Strengths and Difficulties Questionnaire score of = 7) 4. Able to understand English sufficiently to provide informed consent 5. Own an iPhone;Inclusion criteria: Current inclusion criteria (as of 10/08/2018): 1. Recent referral to CAMHS at the point of recruitment 2. Aged 11-19 years 3. Presenting to CAMHS with emotional difficulties, such as anxiety or depression (Strengths and Difficulties Questionnaire score of = 7) 4. Able to understand English sufficiently to provide informed consent 5. Own a smartphone Previous inclusion criteria: 1. Recent referral to CAMHS at the point of recruitment 2. Aged 11-19 years 3. Presenting to CAMHS with emotional difficulties, such as anxiety or depression (Strengths and Difficulties Questionnaire score of = 7) 4. Able to understand English sufficiently to provide informed consent 5. Own an iPhone
Exclusion criteria
Exclusion criteria: Clinician identifies a reason why the young person's vulnerabilities would make them inappropriate to participate;Exclusion criteria: Clinician identifies a reason why the young person's vulnerabilities would make them inappropriate to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Young people: Shared decision making is measured using CollaboRATE, Shared Decision Making Questionnaire – 9, and four items of the ESQ (proxy measure) at baseline and 3 months (for each phase). Clinicians: Shared decision making in young people is assessed using the Dyadic OPTION Scale at baseline and 3 months (for each phase).;Young people: Shared decision making is measured using CollaboRATE, Shared Decision Making Questionnaire – 9, and four items of the ESQ (proxy measure) at baseline and 3 months (for each phase). Clinicians: Shared decision making in young people is assessed using the Dyadic OPTION Scale at baseline and 3 months (for each phase). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Empowerment is measured using the Youth Empowerment Scale – Mental Health 2. Patient activation is measured using the Patient Activation Scale – Mental Health 3. Symptoms of emotional difficulties are measured using the Strengths and Difficulties Questionnaire 4. Service use is measured using the Client Service Receipt Inventory – Children’s Version (parent report) 5. Number of sessions attended, number of Did Not Attends, type of intervention and type of presenting problems will also be reported by clinicians for each participant at three months All measures are taken at baseline (during initial sessions) and three months later unless otherwise stated.;1. Empowerment is measured using the Youth Empowerment Scale – Mental Health 2. Patient activation is measured using the Patient Activation Scale – Mental Health 3. Symptoms of emotional difficulties are measured using the Strengths and Difficulties Questionnaire 4. Service use is measured using the Client Service Receipt Inventory – Children’s Version (parent report) 5. Number of sessions attended, number of Did Not Attends, type of intervention and type of presenting problems will also be reported by clinicians for each participant at three months All measures are taken at baseline (during initial sessions) and three months later unless otherwise stated. | — |
Countries
United Kingdom
Contacts
Public Contact; ;
;
Outcome results
None listed